Company intelligence / Profile preview
鲁南制药集团股份有限公司
- Ownership
- Private
- Employees
- ~15000
- Development stage
- Commercial
Overview
The company has been recognized in the "2024 China Drug R&D Strength Ranking" with listings on four major rankings, indicating ongoing research and development success[1]
- Modalities
- Traditional Chinese medicinechemical drugsbiological products
- Industry
- Pharma
Drug pipeline
1 assetBeyond the preview
Go deeper on 鲁南制药集团股份有限公司.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 鲁南制药集团股份有限公司.